Reshape Lifesciences logo

Reshape Lifesciences share price today

(RSLS)

Reshape Lifesciences share price is $4.86 & ₹417.04 as on 7 Jan 2025, 2.30 'hrs' IST

$4.86

0.16

(3.4%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Reshape Lifesciences share price in Dollar and Rupees. Guide to invest in Reshape Lifesciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Reshape Lifesciences, along with analyst recommendations, forecasts, and comprehensive financials.

Reshape Lifesciences share price movements

  • Today's Low: $4.71
    Today's High: $5.10

    Day's Volatility :7.65%

  • 52 Weeks Low: $4.09
    52 Weeks High: $29.00

    52 Weeks Volatility :85.9%

Reshape Lifesciences Returns

PeriodReshape Lifesciences IncIndex (Russel 2000)
3 Months
-6.37%
0.0%
6 Months
-62.78%
0.0%
1 Year
-64.84%
0.0%
3 Years
-99.89%
-19.8%

Reshape Lifesciences Key Statistics

in dollars & INR

Previous Close
$4.7
Open
$4.75
Today's High
$5.1
Today's Low
$4.71
Market Capitalization
$3.6M
Today's Volume
$16.6K
52 Week High
$29.0
52 Week Low
$4.09
Revenue TTM
$8.0M
EBITDA
$-9.2M
Earnings Per Share (EPS)
$76.2
PE Ratio
0.07
Profit Margin
-112.11%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-184.59%

How to invest in Reshape Lifesciences from India?

It is very easy for Indian residents to invest directly in Reshape Lifesciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Reshape Lifesciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Reshape Lifesciences or RSLS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Reshape Lifesciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Reshape Lifesciences shares which would translate to 0.177 fractional shares of Reshape Lifesciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Reshape Lifesciences, in just a few clicks!

Returns in Reshape Lifesciences for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Reshape Lifesciences investment value today

Current value as on today

₹39,573

Returns

₹60,427

(-60.43%)

Returns from Reshape Lifesciences Stock

₹63,650 (-63.65%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Reshape Lifesciences

57%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Reshape Lifesciences on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 57% more investors are searching Reshape Lifesciences in the last 30 days versus the previous period.

Global Institutional Holdings in Reshape Lifesciences

  • Tower Research Capital LLC

    0.09%

  • BlackRock Inc

    0.08%

Analyst Recommendation on Reshape Lifesciences

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Reshape Lifesciences(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Reshape Lifesciences

What analysts predicted

Downside of 79.42%

Current:

$4.86

Target:

$1.00

Insights on Reshape Lifesciences

  • Price Movement

    In the last 6 months, RSLS stock has moved down by -60.7%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 1.94M → 2.29M (in $), with an average increase of 7.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -2.19M → -1.58M (in $), with an average increase of 19.2% per quarter
  • RSLS vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 55.9% return, outperforming this stock by 120.2%
  • RSLS vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 112.9% return, outperforming this stock by 212.8%
  • Price to Sales

    ForRSLS every $1 of sales, investors are willing to pay $0.2, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Reshape Lifesciences Financials in INR & Dollars

FY18Y/Y Change
Revenue
$606.7K
↓ 52.86%
Net Income
$-81.2M
↑ 139.97%
Net Profit Margin
-13.4K%
↓ 10748.34%
FY19Y/Y Change
Revenue
$15.1M
↑ 2387.02%
Net Income
$-74.2M
↓ 8.56%
Net Profit Margin
-491.8%
↑ 12883.88%
FY20Y/Y Change
Revenue
$11.3M
↓ 25.12%
Net Income
$-21.6M
↓ 70.85%
Net Profit Margin
-191.43%
↑ 300.37%
FY21Y/Y Change
Revenue
$13.6M
↑ 20.36%
Net Income
$-61.9M
↑ 186.33%
Net Profit Margin
-455.39%
↓ 263.96%
FY22Y/Y Change
Revenue
$11.2M
↓ 17.35%
Net Income
$-46.2M
↓ 25.38%
Net Profit Margin
-411.16%
↑ 44.23%
FY23Y/Y Change
Revenue
$8.7M
↓ 22.79%
Net Income
$-11.4M
↓ 75.36%
Net Profit Margin
-131.22%
↑ 279.94%
Q2 FY23Q/Q Change
Revenue
$2.3M
↓ 27.52%
Net Income
$-3.5M
↓ 78.97%
Net Profit Margin
-154.97%
↑ 379.18%
Q3 FY23Q/Q Change
Revenue
$2.2M
↓ 4.39%
Net Income
$-3.5M
↑ 1.17%
Net Profit Margin
-163.99%
↓ 9.02%
Q4 FY23Q/Q Change
Revenue
$2.0M
↓ 8.03%
Net Income
$-1.7M
↓ 51.95%
Net Profit Margin
-85.67%
↑ 78.32%
Q1 FY24Q/Q Change
Revenue
$1.9M
↓ 1.92%
Net Income
$-2.2M
↑ 29.15%
Net Profit Margin
-112.81%
↓ 27.14%
Q2 FY24Q/Q Change
Revenue
$2.0M
↑ 1.08%
Net Income
$-1.6M
↓ 27.27%
Net Profit Margin
-81.17%
↑ 31.64%
Q3 FY24Q/Q Change
Revenue
$2.3M
↑ 16.64%
Net Income
$-1.6M
↓ 0.88%
Net Profit Margin
-68.98%
↑ 12.19%
FY18Y/Y Change
Profit
$442.4K
↑ 26.13%
FY19Y/Y Change
Profit
$9.3M
↑ 2003.25%
FY20Y/Y Change
Profit
$6.3M
↓ 32.7%
FY21Y/Y Change
Profit
$8.3M
↑ 33.31%
FY22Y/Y Change
Profit
$6.8M
↓ 18.52%
FY23Y/Y Change
Profit
$5.5M
↓ 18.44%
Q2 FY23Q/Q Change
Profit
$1.2M
↓ 25.37%
Q3 FY23Q/Q Change
Profit
$1.3M
↑ 7.87%
Q4 FY23Q/Q Change
Profit
$1.8M
↑ 43.01%
Q1 FY24Q/Q Change
Profit
$1.2M
↓ 36.75%
Q2 FY24Q/Q Change
Profit
$1.1M
↓ 2.66%
Q3 FY24Q/Q Change
Profit
$1.4M
↑ 26.9%
FY18Y/Y Change
Operating Cash Flow
$-27.5M
↑ 11.8%
Investing Cash Flow
$-10.3M
↑ 62.2%
Financing Cash Flow
$33.2M
↓ 12.18%
FY19Y/Y Change
Operating Cash Flow
$-14.2M
↓ 48.35%
Investing Cash Flow
$-2.0M
↓ 80.5%
Financing Cash Flow
$13.7M
↓ 58.86%
FY20Y/Y Change
Operating Cash Flow
$-8.6M
↓ 39.79%
Investing Cash Flow
$-2.4M
↑ 18.67%
Financing Cash Flow
$11.1M
↓ 18.92%
FY21Y/Y Change
Operating Cash Flow
$-15.4M
↑ 79.82%
Investing Cash Flow
$1.9M
↓ 177.62%
Financing Cash Flow
$33.3M
↑ 200.67%
FY22Y/Y Change
Operating Cash Flow
$-21.9M
↑ 42.45%
Investing Cash Flow
$-92.0K
↓ 104.96%
Financing Cash Flow
$3.1M
↓ 90.6%
Q2 FY23Q/Q Change
Operating Cash Flow
$-6.7M
↑ 135.41%
Investing Cash Flow
$-3.0K
↓ 57.14%
Financing Cash Flow
$2.3M
↑ 252.66%

Reshape Lifesciences Technicals Summary

Sell

Neutral

Buy

Reshape Lifesciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Reshape Lifesciences Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Reshape Lifesciences Inc
-5.81%
-62.78%
-64.84%
-99.89%
-99.97%
Stryker Corporation
-5.14%
7.73%
20.51%
37.02%
70.83%
Boston Scientific Corp.
2.22%
18.53%
55.24%
113.84%
98.4%
Edwards Lifesciences Corp.
4.25%
-20.93%
-2.33%
-38.47%
-5.21%
Abbott Laboratories
-0.93%
11.99%
1.27%
-15.84%
31.69%
Medtronic Plc
-3.59%
5.29%
-6.49%
-23.36%
-31.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Reshape Lifesciences Inc
0.07
0.07
NA
0.0
-1.85
-0.63
NA
16.48
Stryker Corporation
38.59
38.59
2.51
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
73.82
73.82
1.62
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
28.0
28.0
6.67
2.54
0.19
0.11
NA
16.18
Abbott Laboratories
34.38
34.38
2.19
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
24.43
24.43
1.46
5.45
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Reshape Lifesciences Inc
Buy
$3.6M
-99.97%
0.07
-112.11%
Stryker Corporation
Buy
$137.3B
70.83%
38.59
16.34%
Boston Scientific Corp.
Buy
$131.6B
98.4%
73.82
11.26%
Edwards Lifesciences Corp.
Buy
$43.6B
-5.21%
28.0
65.86%
Abbott Laboratories
Buy
$196.2B
31.69%
34.38
13.99%
Medtronic Plc
Buy
$102.4B
-31.62%
24.43
12.06%

About Reshape Lifesciences

reshape medical is a development-stage medical device manufacturer headquartered in southern california. the company is focused on the development of non-surgical weight loss devices that can be used as aids in the treatment of obese or overweight patients. there are millions of people looking for a solution to assist them in their battle to lose weight, but many are afraid of the risks of surgery. previously, few if any options existed between drugs for weight loss and invasive surgical restructuring of the anatomy. reshape medical intends to broaden the options and is developing less invasive devices for weight loss treatment.
Organization
Reshape Lifesciences
Employees
29
CEO
Mr. Dan W. Gladney
Industry
Medical Specialties

Management People of Reshape Lifesciences

NameTitle
Mr. Dan W. Gladney
Executive Chair
Mr. Paul F. Hickey
CEO, President & Director
Mr. Thomas Stankovich
Senior VP & CFO
Dr. Mark B. Knudson Ph.D.
Co-Founder and Special Advisor to the CEO
Dr. Katherine S. Tweden Ph.D.
Co-Founder
Mr. Al Diaz
Vice President of Operations and R&D
Dr. Dov Gal D.V.M., M.B.A.
VP of Regulatory Clinical Quality & Compliance Officer
Jody B. Dahlman
Director of Communications
Mr. Naqeeb A. Ansari
Senior Vice President of Global Commercial Operations

Important FAQs about investing in Reshape Lifesciences from India :

What is Reshape Lifesciences share price today?

Reshape Lifesciences share price today stands at $4.86, Open: $4.75 ; Previous Close: $4.70 ; High: $5.10 ; Low: $4.71 ; 52 Week High: $29.00 ; 52 Week Low: $4.09. The stock opens at $4.75, after a previous close of $4.70. The stock reached a daily high of $5.10 and a low of $4.71, with a 52-week high of $29.00 and a 52-week low of $4.09.

Can Indians buy Reshape Lifesciences shares?

Yes, Indians can invest in the Reshape Lifesciences (RSLS) from India.

With INDmoney, you can buy Reshape Lifesciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Reshape Lifesciences at zero transaction cost.

How can I buy Reshape Lifesciences shares from India?

It is very easy to buy Reshape Lifesciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Reshape Lifesciences be purchased?

Yes, you can buy fractional shares of Reshape Lifesciences with INDmoney app.

What are the documents required to start investing in Reshape Lifesciences stocks?

To start investing in Reshape Lifesciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Reshape Lifesciences

Today’s highest price of Reshape Lifesciences (RSLS) is $5.10.

Today’s lowest price of Reshape Lifesciences (RSLS) is $4.71.

What is today's market capitalisation of Reshape Lifesciences

Today's market capitalisation of Reshape Lifesciences RSLS is 3.6M

What is the 52 Week High and Low Range of Reshape Lifesciences

  • 52 Week High

    $29.00

  • 52 Week Low

    $4.09

What are the historical returns of Reshape Lifesciences?

  • 1 Month Returns

    -5.81%

  • 3 Months Returns

    -62.78%

  • 1 Year Returns

    -64.84%

  • 5 Years Returns

    -99.97%

Who is the Chief Executive Officer (CEO) of Reshape Lifesciences

Mr. Dan W. Gladney is the current Chief Executive Officer (CEO) of Reshape Lifesciences.